Welcome to the 6th Annual CAR-TCR Summit

The comprehensive forum dedicated to the safe, effective and affordable, clinical and commercial development of CAR and TCR based cell therapies in oncology and beyond.

The CAR-TCR Summit returns to Boston as the industry-leading forum with one goal: to engineer a disease-free world. Bringing together over 1000 CAR and TCR experts from pharma, biotech and academia, this unique platform will provide you with unrivaled networking opportunities with senior level drug developers as well as ground-breaking science and solution-led case studies. Delving into the pioneering developments from early discovery through to late-stage commercialization, this is 4 days your team cannot afford to miss!

"An impactful event that is a must-do for anyone working on CAR-TCR therapies."

HW190321_CART_Slider_designs4[1] advisroy

Expert Scientific Advisory Board

CAR-TCR Boston - Scientific Advisors (1)

Bob Valamehr
Chief Development Officer & Vice President, Cancer Immunotherapy
Fate Therapeutics

CAR-TCR Boston - Scientific Advisors (2)

Adrian Bot
Vice President of Translation
Kite, a Gilead Company

CAR-TCR Boston - Scientific Advisors (3)

Dolores Schendel
Chief Executive Officer

CAR-TCR Boston - Scientific Advisors (4)

Christina Coughlin
Chief Medical Officer
Rubius Therapeutics

CAR-TCR Boston - Scientific Advisors (5)

Bruce Levine
Founding Director, Clinical Cell, Vaccine Production Facility
University of Pennsylvania

HW190321_CART_Slider_designs[1] testimonial GE

Proud to Partner With:

Industry Partners

Other Events in the CAR-TCR Series

As part of the CAR-TCR Series, we are running events in Asia (Shanghai) and in Europe (London). Please visit the individual event pages for more information.

February 24-27, 2020


November 2020